Abstract
MicroRNAs (miRNAs) are involved in tumorigenecity by regulating specific oncogenes and tumor suppressor genes, and their roles in breast cancer stem cells (BCSCs) are becoming apparent. Distinct from the CD44+/CD24−/low sub-population, we have isolated a novel PROCR+/ESA+ BCSC sub-population. To explore miRNA-regulatory mechanisms in this sub-population, we performed miRNA expression profiling and found miR-495 as the most highly upegulated miRNA in PROCR+/ESA+ cells. Coincidently, high upregulation of miR-495 was also found in CD44+/CD24−/low BCSCs, reflecting its potential importance in maintaining common BCSC properties. Ectopic expression of miR-495 in breast cancer cells promoted their colony formation in vitro and tumorigenesis in mice. miR-495 directly suppressed E-cadherin expression to promote cell invasion and inhibited REDD1 expression to enhance cell proliferation in hypoxia through post-transcriptional mechanism. miR-495 expression was directly modulated by transcription factor E12/E47, which itself is highly expressed in BCSCs. These findings reveal a novel regulatory pathway centered on miR-495 that contributes to BCSC properties and hypoxia resistance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF . (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983–3988.
Bartel DP . (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297.
Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E et al. (2004). Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 18: 2893–2904.
Calin GA, Croce CM . (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857–866.
Covello KL, Kehler J, Yu H, Gordan JD, Arsham AM, Hu CJ et al. (2006). HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 20: 557–570.
DeYoung MP, Horak P, Sofer A, Sgroi D, Ellisen LW . (2008). Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev 22: 239–251.
Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555–567.
Gunning P, Leavitt J, Muscat G, Ng SY, Kedes L . (1987). A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA 84: 4831–4835.
Guttilla IK, White BA . (2009). Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 284: 23204–23216.
Heddleston JM, Li Z, Lathia JD, Bao S, Hjelmeland AB, Rich JN . (2010). Hypoxia inducible factors in cancer stem cells. Br J Cancer 102: 789–795.
Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN . (2009). The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8: 3274–3284.
Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S et al. (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202–210.
Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST et al. (2009). Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS One 4: e8377.
Hwang-Verslues WW, Sladek FM . (2008). Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol Endocrinol 22: 78–90.
Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML, Struhl K . (2010a). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39: 493–506.
Iliopoulos D, Lindahl-Allen M, Polytarchou C, Hirsch HA, Tsichlis PN, Struhl K . (2010b). Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Mol Cell 39: 761–772.
Inoki K, Li Y, Xu T, Guan KL . (2003). Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 17: 1829–1834.
Iorio MV, Croce CM . (2009). MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848–5856.
Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D et al. (2004). The UCSC table browser data retrieval tool. Nucleic Acids Res 32: D493–D496.
Keith B, Simon MC . (2007). Hypoxia-inducible factors, stem cells, and cancer. Cell 129: 465–472.
Lewis BP, Burge CB, Bartel DP . (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20.
Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D et al. (2010). miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247–256.
Mamane Y, Petroulakis E, LeBacquer O, Sonenberg N . (2006). mTOR, translation initiation and cancer. Oncogene 25: 6416–6422.
Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S et al. (2010). A MicroRNA targeting dicer for metastasis control. Cell 141: 1195–1207.
Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK et al. (2006). Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24.
McCord AM, Jamal M, Shankavaram UT, Lang FF, Camphausen K, Tofilon PJ . (2009). Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res 7: 489–497.
Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ . (2003). Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425: 962–967.
Murre C, McCaw PS, Vaessin H, Caudy M, Jan LY, Jan YN et al. (1989). Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58: 537–544.
Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL et al. (2003). Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 423: 302–305.
Perez-Moreno MA, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto MA et al. (2001). A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem 276: 27424–27431.
Pietersen AM, Evers B, Prasad AA, Tanger E, Cornelissen-Steijger P, Jonkers J et al. (2008). Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr Biol 18: 1094–1099.
Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R . (2008). MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 105: 1608–1613.
Qi J, Yu JY, Shcherbata HR, Mathieu J, Wang AJ, Seal S et al. (2009). microRNAs regulate human embryonic stem cell division. Cell Cycle 8: 3729–3741.
Reiling JH, Hafen E . (2004). The hypoxia-induced paralogs scylla and charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila. Genes Dev 18: 2879–2892.
Semerad CL, Mercer EM, Inlay MA, Weissman IL, Murre C . (2009). E2A proteins maintain the hematopoietic stem cell pool and promote the maturation of myelolymphoid and myeloerythroid progenitors. Proc Natl Acad Sci USA 106: 1930–1935.
Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D et al. (2009). Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138: 592–603.
Slattery C, McMorrow T, Ryan MP . (2006). Overexpression of E2A proteins induces epithelial-mesenchymal transition in human renal proximal tubular epithelial cells suggesting a potential role in renal fibrosis. FEBS Lett 580: 4021–4030.
Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD et al. (2009). Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28: 3949–3959.
Stefani G, Slack FJ . (2008). Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219–230.
Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD et al. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147–152.
Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL . (2007). Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia 9: 797–800.
Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L . (2008). Brca1 breast tumors contain distinct CD44+/CD24− and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 10: R10.
Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM, Hrushesky WJ . (2009). Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat 117: 423–431.
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C et al. (2007). let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109–1123.
Acknowledgements
This work was supported by Academia Sinica Peak Project (grant number 2371, 4012); and an Academia Sinica Distinguished Postdocotral Fellowship and a Postdocotral Research Fellowship to WWHV. We thank Dr Paul E Verslues (Institute of Plant and Microbial Biology, Academia Sinica) for critical proofreading of the manuscript and Ms Meng-Han Wang for her kind assistance through this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
WHL serves as a member of Board of Directors of GeneTex and has equity interest. This arrangement has been reviewed and approved by the UC Irvine Conflict of Interest committee. The remaining authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website ()
Supplementary information
Rights and permissions
About this article
Cite this article
Hwang-Verslues, W., Chang, PH., Wei, PC. et al. miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1. Oncogene 30, 2463–2474 (2011). https://doi.org/10.1038/onc.2010.618
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.618
Keywords
This article is cited by
-
MiRNA-related metastasis in oral cancer: moving and shaking
Cancer Cell International (2023)
-
FBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance
Oncogene (2023)
-
MicroRNA-495: a therapeutic and diagnostic tumor marker
Journal of Molecular Histology (2023)
-
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3
Journal of Cancer Research and Clinical Oncology (2023)
-
Adhesion of monocytes and endothelial cells isolated from the human aorta suppresses by miRNA-PEI particles
BMC Cardiovascular Disorders (2021)